1. Home
  2. AXGN vs NVAX Comparison

AXGN vs NVAX Comparison

Compare AXGN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$39.07

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.17

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXGN
NVAX
Founded
N/A
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
2013
1996

Fundamental Metrics

Financial Performance
Metric
AXGN
NVAX
Price
$39.07
$8.17
Analyst Decision
Strong Buy
Hold
Analyst Count
8
9
Target Price
$39.25
$11.33
AVG Volume (30 Days)
960.9K
3.1M
Earning Date
04-28-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
309.76
EPS
N/A
2.58
Revenue
$225,208,000.00
$1,123,479,000.00
Revenue This Year
$20.57
N/A
Revenue Next Year
$16.68
N/A
P/E Ratio
N/A
$3.14
Revenue Growth
20.21
64.69
52 Week Low
$9.22
$5.80
52 Week High
$39.99
$11.85

Technical Indicators

Market Signals
Indicator
AXGN
NVAX
Relative Strength Index (RSI) 64.22 41.59
Support Level $29.48 $8.01
Resistance Level $39.99 $8.45
Average True Range (ATR) 2.03 0.34
MACD 0.42 0.02
Stochastic Oscillator 88.56 36.72

Price Performance

Historical Comparison
AXGN
NVAX

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: